Innovent Biologics, Inc. 信達生物製藥

Pay for financial year ended 2023-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Chen, Kaixian 陳凱先 INED 400 164 564
2 Cooney, Charles Leland INED 400 409 809
3 Ede, Ronald Hao Xi 奚浩 FD 2,592 4,511 24,306 31,409
4 Hsu, Joyce I Yin 許懿尹 INED 400 409 809
5 Yu, Michael De Chao 俞德超 Ch, CEO, Pres 2,897 33,547 99,562 136,006
6 Zieziula, Gary INED 400 1,330 1,730
Total 1,600 5,489 38,058 0 126,180 171,327

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,867 7,483 42,949 111 143,703 196,113 Report
2023-12-31 1,600 5,489 38,058 0 126,180 171,327 Report
2022-12-31 1,433 5,384 34,536 0 130,025 171,378 Report
2021-12-31 1,122 5,119 26,500 0 116,707 149,448 Report
2020-12-31 1,122 5,241 18,994 0 94,155 119,512 Report
2019-12-31 1,482 5,241 15,540 165 63,644 86,072 Report
2018-12-31 761 4,201 90,765 142 16,996 112,865 Report
Total 9,387 38,158 267,342 418 691,410 1,006,715

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top